APA

Socié G., Vigouroux S., Yakoub-Agha I., Bay J., Fürst S., Bilger K., Suarez F., Michallet M., Bron D., Gard P., Medeghri Z., Lehert P., Lai C., Corn T. & Vernant J. (20170818). A phase 3 randomized trial comparing inolimomab vs usual care in steroid-resistant acute GVHD. : Blood.

Chicago

Socié Gérard, Vigouroux Stéphane, Yakoub-Agha Ibrahim, Bay Jacques-Olivier, Fürst Sabine, Bilger Karin, Suarez Felipe, Michallet Mauricette, Bron Dominique, Gard Philippe, Medeghri Zakaria, Lehert Philippe, Lai Chinglin, Corn Tim and Vernant Jean-Paul. 20170818. A phase 3 randomized trial comparing inolimomab vs usual care in steroid-resistant acute GVHD. : Blood.

Harvard

Socié G., Vigouroux S., Yakoub-Agha I., Bay J., Fürst S., Bilger K., Suarez F., Michallet M., Bron D., Gard P., Medeghri Z., Lehert P., Lai C., Corn T. and Vernant J. (20170818). A phase 3 randomized trial comparing inolimomab vs usual care in steroid-resistant acute GVHD. : Blood.

MLA

Socié Gérard, Vigouroux Stéphane, Yakoub-Agha Ibrahim, Bay Jacques-Olivier, Fürst Sabine, Bilger Karin, Suarez Felipe, Michallet Mauricette, Bron Dominique, Gard Philippe, Medeghri Zakaria, Lehert Philippe, Lai Chinglin, Corn Tim and Vernant Jean-Paul. A phase 3 randomized trial comparing inolimomab vs usual care in steroid-resistant acute GVHD. : Blood. 20170818.